The Anna Head Alumnae Hall at UC Berkeley was packed with more than 200 attendees Wednesday evening as Feng Zhang, professor of biomedical engineering at the Massachusetts Institute of Technology and ...
Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed ...
The revolution started in silence. No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was ...
The gene-editing startup Aera has hired biotech vets Akin Akinc as CEO and John Maraganore as chairman. The two execs previously led the biotech giant Alnylam. They now guide Feng Zhang's latest ...
The Boston biotech Aera Therapeutics said on Thursday it had raised $193 million. Feng Zhang, Aera's founder and a CRISPR pioneer, spoke with Insider about his vision for the firm. Aera wants to ...
2 women won the Nobel for CRISPR, but the battle for its patent rages on Jennifer Doudna and Emmanuelle Charpentier won the Nobel Prize for figuring out how to use biological mechanisms to edit genes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results